Ricard Cervera

Sobre mi

Publicacions destacades

• Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre

  Autors:

  Barilaro, G; Coloma-Bazan, E; Chacur, A; Cervera, R; Espinosa, G;

  (...)

  Viñas, O; Penella, DT; Reverter, JC; Della Rocca, C; Andujar, AM.

  Veure llistat complet d'autors

  Referència: Autoimmunity Reviews 2022.

• Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study

  Autors:

  Floris, Alberto; Piga, Matteo; Laconi, Riccardo; Espinosa, Gerard; Lopalco, Giuseppe;

  (...)

  Iannone, Florenzo; Cervera, Ricard; Vasconcelos, Carlos; Mathieu, Alessandro; Cauli, Alberto.

  Veure llistat complet d'autors

  Referència: Arthritis Research & Therapy 2022.

• Kidney biopsy in lupus nephritis after achieving clinical renal remission: paving the way for renal outcome assessment

  Autors:

  Lledo-Ibanez, Gema Maria; Xipell, Marc; Ferreira, Manuel; Sole, Manel; Garcia-Herrera, Adriana;

  Cervera, Ricard; Quintana, Luis F; Espinosa, Gerard.

  Referència: Clinical Kidney Journal 2022.

• Why lupus patients discontinue antimalarials in real life: A 50 years-experience from a reference centre

  Autors:

  Araujo, O; Hernandez-Rodriguez, J; Pelegrin, L; Feliu, M; Boland, M;

  Hernandez-Negrin, H; Adan, A; Espinosa, G; Cervera, R.

  Referència: Lupus 2022.

• Persistent Antiphospholipid Antibodies Are Not Associated With Worse Clinical Outcomes in a Prospective Cohort of Hospitalised Patients With SARS-CoV-2 Infection

  Autors:

  Espinosa, G; Neto, D; Cervera, R; Perez-Isidro, A; Prieto-Gonzalez, S;

  Moreno-Castano, AB; Ruiz-Ortiz, E; Zamora-Martinez, C; Bravo-Gallego, LY; Vinas, O.

  Referència: Frontiers In Immunology 2022.

• Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository

  Autors:

  Sevim, E; Zisa, D; Erkan, D; Barbhaiya, M; Andrade, D;

  (...)

  Knight, JS; Atsumi, T; Willis, R; Roubey, R; Bertolaccini, ML.

  Veure llistat complet d'autors

  Referència: Arthritis Care & Research 2022.

• Cost-effectiveness analysis of treatments for the first episode of catastrophic antiphospholipid syndrome: A study based on the catastrophic antiphospholipid syndrome registry

  Autors:

  Quintana-López, G; Maldonado-Cañón, K; Rodríguez-Pintó, I; Espinosa, G; Diaz-Rojas, J;

  Cervera, R.

  Referència: Lupus 2022.

• The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study

  Autors:

  da Rosa, GP; Araújo, O; Barilaro, G; Cervera, R; Espinosa, G;

  Ferreira, E; Bettencourt, P; Sousa-Pinto, B.

  Referència: Arthritis Research & Therapy 2022.

Projectes destacats

• Taxonomy, Treatment, Targets and Remission (3TR): Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

  Investigador/a principal: Luis F Quintana Porras, Ricard Cervera Segura, Juan de Dios Canete Crespillo, Maria Azucena Salas Martinez, Yolanda Blanco Morgado

  Finançador: European Commission

  Codi: CE_IMI2-2018-14

  Durada: 01/09/2019 - 31/08/2026

• Redes de Investigación Cooperativa Orientadas a Resultados en Salud 2021: Enfermedades inflamatorias

  Investigador/a principal: Ricard Cervera Segura

  Finançador: Instituto de Salud Carlos III

  Codi: FIS_RICORS21

  Durada: 01/01/2022 - 31/12/2024

• Estudio multimodal de imagen para el diagnóstico y pronóstico de los pacientes con lupus eritematoso sistémico

  Investigador/a principal: Laura Pelegrin Colas, Gerard Espinosa Garriga

  Finançador: Instituto de Salud Carlos III

  Codi: PI20/01104

  Durada: 01/01/2021 - 31/12/2023

• Papel de las citocinas implicadas en el desarrollo y activación de los linfocitos B y la proteína Dicckopf-3 como marcadores urinarios de fibrosis tubulointersticial en los pacientes con nefritis lúpica

  Investigador/a principal: Luis F Quintana Porras, Marc Xipell Font

  Finançador: Premi Fi de Residència de l´Hospital Clínic de Barcelona

  Durada: 01/01/2021 - 01/01/2023

• Caracterización fenotípica y funcional de linfocitos, monocitos y macrófagos mediante citometría de flujo del sedimento urinario en pacientes con nefritis lúpica para la predicción de enferemdad renal crónica

  Investigador/a principal: Luis F Quintana Porras

  Finançador: Fundación Sociedad Española de Nefrología (SENEFRO)

  Durada: 23/12/2020 - 22/12/2023